Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway

Tumour Biol. 2015 Dec;36(12):9171-7. doi: 10.1007/s13277-015-3641-6. Epub 2015 Jun 19.

Abstract

Aberrant activity of transcription factors in oral squamous cell carcinoma (OSCC) results in the spontaneous secretion of various cytokines and chemokines. Among them, IL-8, owing to its angiogenic activity, promotes the growth of OSCCs. In the present study, we examined the role of IL-8 secreted by OSCCs, on the angiogenic activity of monocytic THP1 cells. Culture supernatant (Ca-sup) augmented IL-8 secretion by THP1 cells, which was found to be significantly reduced following the removal Ca9-22-derived IL-8 from the Ca-sup. IL-8 induction was regulated at the transcriptional level, because real-time PCR demonstrated the augmented IL-8 messenger RNA (mRNA) expression. We further performed the luciferase assay using the 5'-untranslated region of IL-8 gene. Contradictory to our speculations, luciferase activity was not augmented by Ca-sup stimulation. NF-κB-independent IL-8 induction was further confirmed by pre-treating THP1 cells with NF-κB-specific inhibitors. To elucidate the signaling pathway, THP1 was pre-treated with MEK inhibitors. The results demonstrated that pre-treatment of cells with MEK inhibitor drastically reduced IL-8 levels, suggesting the role of MEK. Moreover, Ca-sup was found to increase ERK1/2 phosphorylation in a time-dependent manner. These results indicated that OSCC-derived IL-8 appears to activate angiogenic activity in monocytes within the tumor microenvironment via the mitogen-activated protein kinase (MAPK) pathway.

Keywords: Interleukin-8; Macrophage; Mitogen-activated protein kinase; Oral squamous cell carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Enzyme Inhibitors / administration & dosage
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / genetics*
  • Macrophages / pathology
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / genetics*
  • Monocytes / pathology
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / pathology
  • NF-kappa B / genetics
  • RNA, Messenger / biosynthesis
  • Signal Transduction / drug effects

Substances

  • Enzyme Inhibitors
  • Interleukin-8
  • NF-kappa B
  • RNA, Messenger
  • Mitogen-Activated Protein Kinases